Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Oxid Med Cell Longev ; 2016: 6051093, 2016.
Article in English | MEDLINE | ID: mdl-27034738

ABSTRACT

In erythrocytes, the regulation of the redox sensitive Tyr phosphorylation of band 3 and its functions are still partially defined. A role of band 3 oxidation in regulating its own phosphorylation has been previously suggested. The current study provides evidences to support this hypothesis: (i) in intact erythrocytes, at 2 mM concentration of GSH, band 3 oxidation, and phosphorylation, Syk translocation to the membrane and Syk phosphorylation responded to the same micromolar concentrations of oxidants showing identical temporal variations; (ii) the Cys residues located in the band 3 cytoplasmic domain are 20-fold more reactive than GSH; (iii) disulfide linked band 3 cytoplasmic domain docks Syk kinase; (iv) protein Tyr phosphatases are poorly inhibited at oxidant concentrations leading to massive band 3 oxidation and phosphorylation. We also observed that hemichromes binding to band 3 determined its irreversible oxidation and phosphorylation, progressive hemolysis, and serine hyperphosphorylation of different cytoskeleton proteins. Syk inhibitor suppressed the phosphorylation of band 3 also preventing serine phosphorylation changes and hemolysis. Our data suggest that band 3 acts as redox sensor regulating its own phosphorylation and that hemichromes leading to the protracted phosphorylation of band 3 may trigger a cascade of events finally leading to hemolysis.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Erythrocyte Membrane/metabolism , Signal Transduction , Syk Kinase/metabolism , Female , Humans , Male , Oxidation-Reduction/drug effects , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Syk Kinase/antagonists & inhibitors
3.
Free Radic Biol Med ; 76: 80-8, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25151118

ABSTRACT

Peroxiredoxin-2 (Prx2), a typical two-cysteine peroxiredoxin, is the third most abundant protein in red cells. Although progress has been made in the functional characterization of Prx2, its role in red cell membrane protein homeostasis is still under investigation. Here, we studied Prx2(-/-) mouse red cells. The absence of Prx2 promotes (i) activation of the oxidative-induced Syk pathway; (ii) increased band 3 Tyr phosphorylation, with clustered band 3; and (iii) increased heat shock protein (HSP27 and HSP70) membrane translocation. This was associated with enhanced in vitro erythrophagocytosis of Prx2(-/-) red cells and reduced Prx2(-/-) red cell survival, indicating the possible role of Prx2 membrane recruitment in red cell aging and in the clearance of oxidized hemoglobin and damaged proteins through microparticles. Indeed, we observed an increased release of microparticles from Prx2(-/-) mouse red cells. The mass spectrometric analysis of erythroid microparticles found hemoglobin chains, membrane proteins, and HSPs. To test these findings, we treated Prx2(-/-) mice with antioxidants in vivo. We observed that N-acetylcysteine reduced (i) Syk activation, (ii) band 3 clusterization, (iii) HSP27 membrane association, and (iv) erythroid microparticle release, resulting in increased Prx2(-/-) mouse red cell survival. Thus, we propose that Prx2 may play a cytoprotective role in red cell membrane protein homeostasis and senescence.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Cellular Senescence , Erythrocytes/metabolism , HSP27 Heat-Shock Proteins/metabolism , HSP70 Heat-Shock Proteins/metabolism , Homeodomain Proteins/physiology , Homeostasis/physiology , Intracellular Signaling Peptides and Proteins/metabolism , Protein-Tyrosine Kinases/metabolism , Acetylcysteine/pharmacology , Animals , Antioxidants/pharmacology , Cell Survival , Erythrocytes/cytology , Female , Hydrogen Peroxide/pharmacology , Immunoblotting , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxidants/pharmacology , Oxidative Stress/drug effects , Syk Kinase
4.
Haematologica ; 99(3): 570-8, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24038029

ABSTRACT

High counts of circulating microparticles, originated from the membrane of abnormal erythrocytes, have been associated with increased thrombotic risk in hemolytic disorders. Our studies indicate that in thalassemia intermedia patients the number of circulating microparticles correlates with the capability of the thalassemic erythrocytes to release microparticles. The microparticles are characteristically loaded with hemichromes formed by denatured α-chains. This finding was substantiated by the positive correlation observed in thalassemia intermedia patients between the amount of hemichromes measured in erythrocytes, their capability to release microparticles and the levels of plasma hemichromes. We observed that hemichromes, following their binding to the cytoplasmic domain of band 3, induce the formation of disulfide band 3 dimers that are subsequently phosphorylated by p72Syk kinase. Phosphorylation of oxidized band 3 appears to be relevant for the formation of large hemichromes/band 3 clusters that, in turn, induce local membrane instability and the release of microparticles. Proteomic analysis of microparticles released from thalassemia intermedia erythrocytes indicated that, besides hemichromes and clustered band 3, the microparticles contain a characteristic set of proteins that includes catalase, heat shock protein 70, peroxiredoxin 2 and carbonic anhydrase. High amounts of immunoglobulins and C3 have also been found to be associated with microparticles, accounting for their intense phagocytosis. The effect of p72Syk kinase inhibitors on the release of microparticles from thalassemia intermedia erythrocytes may indicate new perspectives for controlling the release of circulating microparticles in hemolytic anemias.


Subject(s)
Cell-Derived Microparticles/metabolism , Erythrocytes/metabolism , Hemeproteins/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Protein-Tyrosine Kinases/metabolism , Thalassemia/metabolism , Enzyme Activation , Erythrocytes/drug effects , Humans , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Oxidation-Reduction , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors , Syk Kinase , Thalassemia/blood
5.
Oxid Med Cell Longev ; 2013: 985210, 2013.
Article in English | MEDLINE | ID: mdl-24205432

ABSTRACT

ß-thalassemia is a worldwide distributed monogenic red cell disorder, characterized by the absence or reduced ß -globin chain synthesis. Despite the extensive knowledge of the molecular defects causing ß-thalassemia, less is known about the mechanisms responsible for the associated ineffective erythropoiesis and reduced red cell survival, which sustain anemia of ß-thalassemia. The unbalance of alpha-gamma chain and the presence of pathological free iron promote a severe red cell membrane oxidative stress, which results in abnormal ß-thalassemic red cell features. These cells are precociously removed by the macrophage system through two mechanisms: the removal of phosphatidylserine positive cells and through the natural occurring antibody produced against the abnormally clustered membrane protein band 3. In the present review we will discuss the changes in ß-thalassemic red cell homeostasis related to the oxidative stress and its connection with production of microparticles and with malaria infection. The reactive oxygen species (ROS) are also involved in ineffective erythropoiesis of ß-thalassemia through still partially known pathways. Novel cytoprotective systems such as ASHP, eIF2 α, and peroxiredoxin-2 have been suggested to be important against ROS in ß-thalassemic erythropoiesis. Finally, we will discuss the results of the major in vitro and in vivo studies with antioxidants in ß -thalassemia.


Subject(s)
Erythroid Cells/pathology , Oxidative Stress , beta-Thalassemia/pathology , Animals , Cytoprotection , Erythrocytes/pathology , Humans , Malaria/pathology
6.
J Proteomics ; 76 Spec No.: 251-8, 2012 Dec 05.
Article in English | MEDLINE | ID: mdl-22960126

ABSTRACT

Malaria parasites interact with the host cell membrane inserting new proteins and inducing oxidative and phosphorylative changes of erythrocyte proteins. In the present report we monitored the time dependent oxidative and phosphorylative modifications induced by parasites in heterozygous beta thalassemia (Het-ßThal). Het-ßThal causes mild anemia and is known to determine a pro-oxidant milieu and a protective effect against severe malaria. In malaria cultures Het-ßThal has been reported to induce accumulation of hemoglobin denaturation products. At early parasite development stages (rings), tyrosine hyper-phosphorylation of band 3 was the most notable modification, and at later development stages (trophozoites), additional membrane proteins displayed significant hyper-phosphorylation of their serine and tyrosine residues (adducins, ankyrin, catalase). Het-ßThal also caused membrane destabilization. Free radical scavengers effectively inhibited the phosphorylative response and membrane destabilization. Kinase inhibitors exerted similar effects suggesting a causal relationship between oxidative stress, membrane protein hyper-phosphorylation and increased membrane damage exacerbated by Het-ßThal. In conclusion, different lines of evidence suggest that Het-ßThal enhances the redox stress caused by malaria parasites inducing its protective effect destabilizing the host cell membrane. This article is part of a Special Issue entitled: Integrated omics.


Subject(s)
Erythrocyte Membrane/metabolism , Heterozygote , Malaria, Falciparum/metabolism , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Plasmodium falciparum/metabolism , beta-Thalassemia/metabolism , Adult , Erythrocyte Membrane/genetics , Erythrocyte Membrane/parasitology , Female , Humans , Malaria, Falciparum/genetics , Male , Oxidation-Reduction , Oxidative Stress , Phosphorylation , beta-Thalassemia/genetics , beta-Thalassemia/parasitology
7.
Blood Transfus ; 10 Suppl 2: s55-62, 2012 May.
Article in English | MEDLINE | ID: mdl-22890269

ABSTRACT

BACKGROUND: During blood bank storage, red blood cells (RBCs) undergo a number of biological and biochemical alterations collectively referred to as "storage lesions". These injuries include loss and oxidative cross-linking of band 3, the major integral protein of RBC membranes. Denaturation of hemoglobin (Hb) and damage to the amino-terminal of band 3 are recognised as the starting events for immunological recognition mechanisms and phagocytic removal of senescent or impaired RBCs from circulation. Consequently, studies focusing on the Hb-association and oxidative status of the cytoskeleton of stored RBCs intended for transfusion are of extreme interest. In this work, two storage-related fragments of band 3 were documented and biochemically characterised. METHODS: Four RBC units were collected from normal volunteers and stored for 21 days under (i) standard blood bank conditions, (ii) anaerobic conditions, or (iii) in the presence of caspase 3-inhibitor. Degradation products of band 3 were followed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis coupled with western blot and mass spectrometry analyses. RESULTS: Two different degradation products of the cytoplasmic domain of the erythrocyte band 3 (CDB3) were detected in RBC membranes during storage in saline-adenine-glucosemannitol (SAGM) preservation medium. One of these fragments showed an apparent molecular weight of 34 kDa and was demonstrated to be the product of a free-radical attack on the protein main chain, whereas another fragment of 24 kDa was the result of a caspase 3-mediated cleavage. DISCUSSION: Although to different extent, anaerobic conditions reduced the formation of both truncated products indicating an enhanced activity of the pro-apoptotic caspase 3 enzyme following oxidative stress. Interestingly, both CDB3 fragments were tightly associated to the erythrocyte membrane supporting the involvement of Cys-201 and/or Cys-317 in clustering different band 3 monomers.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Blood Preservation , Caspases/physiology , Erythrocyte Membrane/metabolism , Erythrocyte Membrane/pathology , Erythrocytes/metabolism , Erythrocytes/pathology , Oxidative Stress , Humans
8.
Electrophoresis ; 33(16): 2546-52, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22899262

ABSTRACT

A constantly increasing number of mABs are required for the validation of a large proportion of proteomic and protein-protein interaction data. The development of new robotic platforms has greatly enhanced the throughput of monoclonal antibody production; however, the availability of highly purified proteins to use as antigens currently represents the major bottleneck of the process. In this article, we describe a new 2DE approach to purify hundreds of proteins from cellular extracts in a very cost-effective and time-efficient way. The accuracy of the new purification method is shown to be comparable to high-resolution analytical 2DE. The effectiveness and the throughput of the method to purify proteins suitable for the development of mAbs are then assessed. Using this methodology, we were able to separate 447 proteins starting from 50 mg of proteins extracted from HT29 cells. Fractions containing more than 30 µg of protein constantly induced immunization in mice. Using a high-throughput process for monoclonal antibody production, we obtained an average of 3.5 mAbs for each protein. According to pilot experiments, we can predict that starting from an unfractionated cellular extract it is possible to obtain approximately 200 proteins usable for monoclonal antibody development. Our results indicate that the number of antigens available for monoclonal antibody production can be further increased by running parallel separations. The proposed methodology will then facilitate the high-throughput monoclonal antibody process providing a vast array of high quality antigens at very low cost.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antigens/isolation & purification , Electrophoresis, Gel, Two-Dimensional/methods , High-Throughput Screening Assays/methods , Proteins/isolation & purification , Animals , Antibodies, Monoclonal/immunology , Antigens/administration & dosage , Antigens/immunology , Cell Extracts/chemistry , HT29 Cells , Humans , Immunization , Mice , Mice, Inbred BALB C , Proteins/administration & dosage , Proteins/immunology
9.
J Infect Dev Ctries ; 6(6): 536-41, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-22706198

ABSTRACT

INTRODUCTION: We propose a new method for the selective labeling, isolation and electrophoretic analysis of the Plasmodium falciparum protein exposed on the erythrocyte cell surface. Historically, membrane surface proteins have been isolated using a surface biotinylation followed by capture of biotin-conjugated protein via an avidin/streptavidin-coated solid support. The major drawback of the standard methods has been the labeling of internal proteins due to fast internalization of biotin. METHODOLOGY: To solve this problem, we used a biotin label that does not permeate through the membrane. As a further precaution to avoid the purification of non surface exposed proteins, we directly challenged whole labeled cells with avidin coated beads and then solubilized them using non ionic detergents. RESULTS: A marked enrichment of most of the RBC membrane proteins known to face the external surface of the membrane validated the specificity of the method; furthermore, only small amounts of haemoglobin and cytoskeletal proteins were detected. A wide range of P. falciparum proteins were additionally described to be exposed on the erythrocyte surface. Some of them have been previously observed and used as vaccine candidates while a number of newly described antigens have been presently identified. Those antigens require further characterization and validation with additional methods. CONCLUSION: Surface proteins preparations were very reproducible and identification of proteins by mass spectrometry has been demonstrated to be feasible and effective.


Subject(s)
Erythrocytes/parasitology , Membrane Proteins/analysis , Parasitology/methods , Plasmodium falciparum/chemistry , Protozoan Proteins/analysis , Adult , Biotin/metabolism , Female , Humans , Male , Mass Spectrometry , Membrane Proteins/isolation & purification , Plasmodium falciparum/pathogenicity , Protozoan Proteins/isolation & purification , Sensitivity and Specificity , Staining and Labeling/methods
10.
Free Radic Biol Med ; 52(2): 527-36, 2012 Jan 15.
Article in English | MEDLINE | ID: mdl-22142474

ABSTRACT

Although indolone-N-oxide (INODs) genereting long-lived radicals possess antiplasmodial activity in the low-nanomolar range, little is known about their mechanism of action. To explore the molecular basis of INOD activity, we screened for changes in INOD-treated malaria-infected erythrocytes (Pf-RBCs) using a proteomics approach. At early parasite maturation stages, treatment with INODs at their IC(50) concentrations induced a marked tyrosine phosphorylation of the erythrocyte membrane protein band 3, whereas no effect was observed in control RBCs. After INOD treatment of Pf-RBCs we also observed: (i) accelerated formation of membrane aggregates containing hyperphosphorylated band 3, Syk kinase, and denatured hemoglobin; (ii) dose-dependent release of microvesicles containing the membrane aggregates; (iii) reduction in band 3 phosphorylation, Pf-RBC vesiculation, and antimalarial effect of INODs upon addition of Syk kinase inhibitors; and (iv) correlation between the IC(50) and the INOD concentrations required to induce band 3 phosphorylation and vesiculation. Together with previous data demonstrating that tyrosine phosphorylation of oxidized band 3 promotes its dissociation from the cytoskeleton, these results suggest that INODs cause a profound destabilization of the Pf-RBC membrane through a mechanism apparently triggered by the activation of a redox signaling pathway rather than direct oxidative damage.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Antimalarials/pharmacology , Cell Membrane/drug effects , Cyclic N-Oxides/pharmacology , Free Radicals/chemistry , Indoles/pharmacology , Malaria, Falciparum/parasitology , Phosphotyrosine/metabolism , Plasmodium falciparum/growth & development , Cell Membrane/metabolism , Erythrocytes/drug effects , Erythrocytes/metabolism , Erythrocytes/parasitology , Female , Humans , Male , Membrane Proteins/metabolism , Phosphorylation , Plasmodium falciparum/drug effects , Protein Multimerization , Proteome/metabolism
11.
Blood ; 118(20): 5652-63, 2011 Nov 17.
Article in English | MEDLINE | ID: mdl-21951684

ABSTRACT

Acanthocytic RBCs are a peculiar diagnostic feature of chorea-acanthocytosis (ChAc), a rare autosomal recessive neurodegenerative disorder. Although recent years have witnessed some progress in the molecular characterization of ChAc, the mechanism(s) responsible for generation of acanthocytes in ChAc is largely unknown. As the membrane protein composition of ChAc RBCs is similar to that of normal RBCs, we evaluated the tyrosine (Tyr)-phosphorylation profile of RBCs using comparative proteomics. Increased Tyr phosphorylation state of several membrane proteins, including band 3, ß-spectrin, and adducin, was noted in ChAc RBCs. In particular, band 3 was highly phosphorylated on the Tyr-904 residue, a functional target of Lyn, but not on Tyr-8, a functional target of Syk. In ChAc RBCs, band 3 Tyr phosphorylation by Lyn was independent of the canonical Syk-mediated pathway. The ChAc-associated alterations in RBC membrane protein organization appear to be the result of increased Tyr phosphorylation leading to altered linkage of band 3 to the junctional complexes involved in anchoring the membrane to the cytoskeleton as supported by coimmunoprecipitation of ß-adducin with band 3 only in ChAc RBC-membrane treated with the Lyn-inhibitor PP2. We propose this altered association between membrane skeleton and membrane proteins as novel mechanism in the generation of acanthocytes in ChAc.


Subject(s)
Acanthocytes/enzymology , Erythrocyte Membrane/enzymology , Neuroacanthocytosis/metabolism , src-Family Kinases/metabolism , Acanthocytes/pathology , Adult , Anion Exchange Protein 1, Erythrocyte/metabolism , Cytoskeletal Proteins/metabolism , Cytoskeleton/metabolism , Enzyme Activation/physiology , Erythrocyte Membrane/pathology , Female , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Male , Middle Aged , Neuroacanthocytosis/pathology , Phosphorylation/physiology , Protein-Tyrosine Kinases/metabolism , Proteomics , Syk Kinase , Tyrosine/metabolism
12.
Blood ; 117(22): 5998-6006, 2011 Jun 02.
Article in English | MEDLINE | ID: mdl-21474668

ABSTRACT

The cytoplasmic domain of band 3 serves as a center of erythrocyte membrane organization and constitutes the major substrate of erythrocyte tyrosine kinases. Tyrosine phosphorylation of band 3 is induced by several physiologic stimuli, including malaria parasite invasion, cell shrinkage, normal cell aging, and oxidant stress (thalassemias, sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, etc). In an effort to characterize the biologic sequelae of band 3 tyrosine phosphorylation, we looked for changes in the polypeptide's function that accompany its phosphorylation. We report that tyrosine phosphorylation promotes dissociation of band 3 from the spectrin-actin skeleton as evidenced by: (1) a decrease in ankyrin affinity in direct binding studies, (2) an increase in detergent extractability of band 3 from ghosts, (3) a rise in band 3 cross-linkability by bis-sulfosuccinimidyl-suberate, (4) significant changes in erythrocyte morphology, and (5) elevation of the rate of band 3 diffusion in intact cells. Because release of band 3 from its ankyrin and adducin linkages to the cytoskeleton can facilitate changes in multiple membrane properties, tyrosine phosphorylation of band 3 is argued to enable adaptive changes in erythrocyte biology that permit the cell to respond to the above stresses.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Cytoskeleton/metabolism , Erythrocyte Membrane/metabolism , Erythrocytes/metabolism , Tyrosine/metabolism , Actins/metabolism , Ankyrins/metabolism , Cell Membrane/metabolism , Cross-Linking Reagents/pharmacology , Erythrocytes/drug effects , Humans , Immunoblotting , Phosphorylation/drug effects , Protein Binding , Vanadates/pharmacology
13.
PLoS One ; 6(1): e15847, 2011 Jan 05.
Article in English | MEDLINE | ID: mdl-21246053

ABSTRACT

BACKGROUND: While G6PD deficiency is one of the major causes of acute hemolytic anemia, the membrane changes leading to red cell lysis have not been extensively studied. New findings concerning the mechanisms of G6PD deficient red cell destruction may facilitate our understanding of the large individual variations in susceptibility to pro-oxidant compounds and aid the prediction of the hemolytic activity of new drugs. METHODOLOGY/PRINCIPAL FINDINGS: Our results show that treatment of G6PD deficient red cells with diamide (0.25 mM) or divicine (0.5 mM) causes: (1) an increase in the oxidation and tyrosine phosphorylation of AE1; (2) progressive recruitment of phosphorylated AE1 in large membrane complexes which also contain hemichromes; (3) parallel red cell lysis and a massive release of vesicles containing hemichromes. We have observed that inhibition of AE1 phosphorylation by Syk kinase inhibitors prevented its clustering and the membrane vesiculation while increases in AE1 phosphorylation by tyrosine phosphatase inhibitors increased both red cell lysis and vesiculation rates. In control RBCs we observed only transient AE1 phosphorylation. CONCLUSIONS/SIGNIFICANCE: Collectively, our findings indicate that persistent tyrosine phosphorylation produces extensive membrane destabilization leading to the loss of vesicles which contain hemichromes. The proposed mechanism of hemolysis may be applied to other hemolytic diseases characterized by the accumulation of hemoglobin denaturation products.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Erythrocyte Membrane/pathology , Glucosephosphate Dehydrogenase Deficiency/pathology , Protein-Tyrosine Kinases/metabolism , Erythrocyte Membrane/ultrastructure , Hemoglobins/metabolism , Hemolysis , Humans , Oxidants/pharmacology , Phosphorylation/drug effects , Tyrosine/metabolism
14.
Proteomics ; 10(19): 3469-79, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20799346

ABSTRACT

Phosphorylation of erythrocyte membrane proteins has been previously documented following infection and intracellular growth of the malarial parasite, Plasmodium falciparum in red cells. Much of this data dealt with phosphorylation of serine residues. In this study, we report detailed characterization of phosphorylation of serine and tyrosine residues of red cell membrane proteins following infection by P falciparum. Western blot analysis using anti-phosphotyrosine and anti-phosphoserine antibodies following 2-DE in conjunction with double channel laser-induced infrared fluorescence enabled accurate assessment of phosphorylation changes. Tyrosine phosphorylation of band 3 represented the earliest modification observed during parasite development. Band 3 tyrosine phosphorylation observed at the ring stage appears to be under the control of Syk kinase. Serine and tyrosine phosphorylation of additional cytoskeletal, trans-membrane and membrane associated proteins was documented as intracellular development of parasite progressed. Importantly, during late schizont stage of parasite maturation, we observed widespread protein dephosphorylation. In vitro treatments that caused distinct activation of red cell tyrosine and serine kinases elicited phosphorylative patterns similar to what observed in parasitized red blood cell, suggesting primary involvement of erythrocyte kinases. Identification of tyrosine phosphorylations of band 3, band 4.2, catalase and actin which have not been previously described in P. falciparum infected red cells suggests new potential regulatory mechanisms that could modify the functions of the host cell membrane.


Subject(s)
Erythrocyte Membrane/parasitology , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Plasmodium falciparum/physiology , Serine/metabolism , Tyrosine/metabolism , Erythrocyte Membrane/metabolism , Host-Parasite Interactions , Humans , Malaria, Falciparum/parasitology , Malaria, Falciparum/physiopathology , Phosphorylation , Plasmodium falciparum/growth & development
16.
J Proteomics ; 73(3): 445-55, 2010 Jan 03.
Article in English | MEDLINE | ID: mdl-19758581

ABSTRACT

With the advent of proteomic techniques the number of known post-translational modifications (PTMs) affecting red cell membrane proteins is rapidly growing but the understanding of their role under physiological and pathological conditions is incompletely established. The wide range of hereditary diseases affecting different red cell membrane functions and the membrane modifications induced by malaria parasite intracellular growth represent a unique opportunity to study PTMs in response to variable cellular stresses. In the present review, some of the major areas of interest in red cell membrane research have been considered as modifications of erythrocyte deformability and maintenance of the surface area, membrane transport alterations, and removal of diseased and senescent red cells. In all mentioned research areas the functional roles of PTMs are prevalently restricted to the phosphorylative changes of the more abundant membrane proteins. The insufficient information about the PTMs occurring in a large majority of the red membrane proteins and the general lack of mass spectrometry data evidence the need of new comprehensive, proteomic approaches to improve the understanding of the red cell membrane physiology.


Subject(s)
Disease , Erythrocyte Membrane/metabolism , Erythrocytes , Membrane Proteins/metabolism , Protein Kinases/metabolism , Protein Processing, Post-Translational/physiology , Biological Transport/physiology , Disease/etiology , Erythrocyte Aging/physiology , Erythrocyte Deformability/physiology , Erythrocytes/cytology , Erythrocytes/metabolism , Erythrocytes/pathology , Humans , Knowledge , Membrane Proteins/analysis , Phosphorylation/physiology
17.
Biochem J ; 418(2): 359-67, 2009 Mar 01.
Article in English | MEDLINE | ID: mdl-18945214

ABSTRACT

Oxidative events involving band 3 (Anion Exchanger 1) have been associated with RBC (red blood cell) removal through binding of NAbs (naturally occurring antibodies); however, the underlying mechanism has been only partially characterized. In addition to inducing direct membrane protein oxidative modification, oxidative treatment specifically triggers the phosphorylation of band 3 tyrosine residues. The present study reports that diamide, a thiol group oxidant, induces disulfide cross-linking of poorly glycosylated band 3 and that the oligomerized band 3 fraction is selectively tyrosine phosphorylated both in G6PD (glucose-6-phosphate dehydrogenase)-deficient and control RBCs. This phenomenon is irreversible in G6PD-deficient RBCs, whereas it is temporarily limited in control RBCs. Diamide treatment caused p72 Syk phosphorylation and translocation to the membrane. Diamide also induced p72 Syk co-immunoprecipitation with aggregated band 3. Moreover, following size-exclusion separation of Triton X-100-extracted membrane proteins, Syk was found only in the high-molecular-mass fraction containing oligomerized/phosphorylated band 3. Src family inhibitors efficiently abrogated band 3 tyrosine phosphorylation, band 3 clustering and NAbs binding to the RBC surface, suggesting a causal relationship between these events. Experiments performed with the non-permeant cross-linker BS(3) (bis-sulfosuccinimidyl-suberate) showed that band 3 tyrosine phosphorylation enhances its capability to form large aggregates. The results of the present study suggest that selective tyrosine phosphorylation of oxidized band 3 by Syk may play a role in the recruitment of oxidized band 3 in large membrane aggregates that show a high affinity to NAbs, leading to RBC removal from the circulation.


Subject(s)
Anion Exchange Protein 1, Erythrocyte/metabolism , Erythrocytes/pathology , Glucosephosphate Dehydrogenase Deficiency/pathology , Intracellular Signaling Peptides and Proteins/metabolism , Protein Multimerization , Protein-Tyrosine Kinases/metabolism , Antibodies/metabolism , Antibodies/physiology , Diamide/pharmacology , Erythrocytes/metabolism , Glucosephosphate Dehydrogenase/genetics , Glucosephosphate Dehydrogenase/metabolism , Glucosephosphate Dehydrogenase Deficiency/blood , Glucosephosphate Dehydrogenase Deficiency/metabolism , Glycosylation , Humans , Membrane Proteins/metabolism , Models, Biological , Oxidation-Reduction , Phosphorylation , Protein Binding , Protein Multimerization/genetics , Protein Multimerization/physiology , Substrate Specificity , Sulfhydryl Reagents/pharmacology , Syk Kinase , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...